Received: 15 January 2021
Accepted: 4 June 2021
First Online: 9 July 2021
: Ethics approval was not required for this systematic review.
: All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria.
: Dr. Whitlock reports grants from Bayer, Roche, and Boeringer-Ingelheim outside the submitted work. He also reports speaker honorarium from Boeringer-Ingelheim and consultancy for AtriCure and PhaseBio outside the submitted work.Dr. Belley-Cote reports grants from Bayer and Roche outside this submitted work.The other authors have no conflict of interest.